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Abstract: Blood vessel reconstruction is still an elusive goal for the development of in vitro models
as well as artificial vascular grafts. In this study, we used a novel photo-curable cytocompatible
polyacrylate material (PA) for freeform generation of synthetic vessels. We applied stereolithography
for the fabrication of arbitrary 3D tubular structures with total dimensions in the centimeter range,
300 µm wall thickness, inner diameters of 1 to 2 mm and defined pores with a constant diameter of
approximately 100 µm or 200 µm. We established a rinsing protocol to remove remaining cytotoxic
substances from the photo-cured PA and applied thio-modified heparin and RGDC-peptides to
functionalize the PA surface for enhanced endothelial cell adhesion. A rotating seeding procedure
was introduced to ensure homogenous endothelial monolayer formation at the inner luminal tube
wall. We showed that endothelial cells stayed viable and adherent and aligned along the medium flow
under fluid-flow conditions comparable to native capillaries. The combined technology approach
comprising of freeform additive manufacturing (AM), biomimetic design, cytocompatible materials
which are applicable to AM, and biofunctionalization of AM constructs has been introduced as
BioRap® technology by the authors.
Keywords: stereolithography; artificial blood vessel; small branched and porous tubes;
biofunctionalization; thio-modified heparin; endothelialization
1. Introduction
New materials for additive manufacturing (AM) methods are gaining more and more interest
for applications in medical engineering and medicine. Computer-based AM techniques can directly
transform digital data into physical objects through layer-by-layer material deposition or layerwise
material solidification. One particular focus is on photo-curable polymers for laser-based additive
assembly of complex or individualized three-dimensional (3D) structures. In recent years, AM has
already been utilized for assembling patient specific models from 3D images acquired by computer
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tomography or surface scanning enabling surgeons to plan complex interventions, to pre-adjust
implants or to fabricate individualized surgical guides [1,2]. Future applications will increasingly
comprise the fabrication of biocompatible and biofunctional scaffolds for the development of tissue
models and implants with an individual shape [3]. Blood vessel reconstruction is of particular
interest for both the development of in vitro models and artificial vascular prostheses. While the
material specification list for blood vessel replacement in vivo is long and extremely challenging [4],
the basic requirements for tubular supply systems for 3D tissue engineering are permeability and
cytocompatibility. The inability to provide a sufficient and functional blood vessel system today is
one of the main limitations in obtaining thick viable tissue models with the potential of mimicking
the complex functions of native tissue [5]. With regard to the supply of several cubic millimeters of
cells in a 3D matrix, tubular systems with single inlet, multiple branches, single outlet, and adjustable
geometry are required. Endothelial cell adhesion and monolayer formation at the inner tube surface
are additional prerequisites for simulating the controlled exchange of substances across the endothelial
barrier. Fabrication of porous tubes has been realized earlier, e.g., by freeze-drying of biopolymers [6]
or by electro-spinning of a broad range of materials [7,8]. Extrusion of bio-based materials and
blends using coaxial nozzles also resulted in hollow fibers, which can eventually be perfused [9,10].
As drawback, such methods cannot produce branched structures. With shaping techniques, such as
nanoimprint lithography or microcontact printing, more complex and branched microfluidic channels
have been created [11–13]. However, the micro-channels thus produced are limited in application
in engineering larger tissues [11,14]. The newly emerging AM techniques are now increasingly
implemented to fabricate perfusable structures in a broad range of scales. We have recently reviewed
current approaches to (bio-)printing of artificial blood vessels [15]. The most straightforward approach
to perfusable tissue supply systems is the generation of a network of interconnected channels within
the tissue matrix [16–18]. This has been achieved by extrusion-based deposition of branched networks
of sacrificial materials such as carbohydrates, which were removed after a crosslinked cell-laden matrix
had been added. Alternatively, hydrogel-based tubular structures with very high aspect ratios have,
e.g., been fabricated by assembly of microspheres of crosslinked alginate, which formed by ejection of
alginate droplets into a solution of CaCl2 [19,20]. Complex geometries such as that of branched blood
vessels are now increasingly implemented in various scales by the newly emerging AM techniques.
One major challenge is to support free-standing structures during buildup. Branched geometries
have been assembled by the combined deposition of building materials and support materials [21,22].
The dimensions of such model structures are still in the centimeter range. Laser-based methods,
e.g., stereolithography, two-photon-polymerization or digital light processing, induce solidifying of a
photo-curable resin by layerwise selective crosslinking, and thus avoid the need of additional support.
Such techniques have also been used to generate very tiny branched structures [23] or microstructured
vessel walls [24] using acrylated polymers. Thus, obviously, the use of AM techniques has brought
us closer towards the construction of perfusable tissue models and provides an alternative to the use
of decellularized biological donor scaffolds. Consequently, there is a comprehensive need for new
biomaterials capable of being applied in AM processes.
We have previously developed new material formulations which can be used for AM applications
and tissue culture due to photo-reactivity, cytocompatibility, adjustable viscosity and the ability to
tune the elastic properties of the cured materials [23,25,26]. However, synthetic materials that have
been primarily adjusted to be processed in AM techniques are not necessarily cytocompatible or
support cell adhesion. In this study, we suggest using thio-modified heparin and cysteine-coupled
arginine-glycine-aspartic acid (RGDC) peptides for biofunctionalization of polyacrylate surfaces.
We introduce the stereolithography-based method to fabricate porous tubes and branched tubular
systems with 17 mm total length, 12 mm total width, and defined 100 µm pores from a novel acrylate
based resin. A rinsing protocol was established to achieve cytocompatibility of the photo-cured
material. Further, a seeding procedure with endothelial cells in a fluid-flow bioreactor with shear rates
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comparable to native capillaries was established for endothelial monolayer formation on the tube’s
luminal surface in vitro.
2. Results
2.1. Post-Curing Treatments of UV-Cured PA
We developed an acrylate resin that is applicable in printing processes as well as for
laser-based curing by stereolithography. We investigated UV-cured films in terms of post-curing
treatments. Post-curing comprised a rinsing protocol in ethanol (EtOH, 70%) to achieve
PA cytocompatibility, PA immersion within physiological buffer solution (PBS), and gamma
(γ)-sterilization. Cytocompatibility testing was performed in a general way using fibroblast cells
as recommended in DIN ISO 10993-5 [27]. Compatibility with endothelial cells was further confirmed
by the seeding experiments of the material described in Section 2.4.
Rinsing in EtOH (70%) for five days increased the cytocompatibility of UV-cured PA from
31% ˘ 6.7% fibroblast viability on day one to 97% ˘ 7.2% on day five in relation to standard tissue
culture petri dish (TCPD) substrates (Figure 1). Subsequent removal of EtOH by evacuation was
crucial to achieve the cytocompatibility.
J. Funct. Biomater. 2016, 7, 11 
3 
2. Results 
. .  ost‐ ri   reat e ts of  ‐ re    
 developed an acrylate r sin that is  pplic ble in printing processes as well as for laser‐based 
curing by  stereolithography. We  investigated UV‐cured  films  in  terms of post‐curing  treatments. 
Post‐curing comprised a rinsing protocol in ethanol (EtOH, 70%) to achieve PA cytocompatibility, 
  immersion  within  physiological  buffer  soluti n  (PBS),  and  gamma  ()‐sterilization. 
Cytocomp tibility testing w s performed in a general way using fibroblast cells as recommended in 
DIN  ISO 10993‐5  [27]. Compatibility with endothelial cells was  further confirmed by  the seeding 
experiments of the material described in Section 2.4. 
i si  in EtOH (70%) for five days increased the cytocompatibility of UV‐cured PA from 31% 
± 6.7% fibroblast viability on day one to 97% ± 7.2  on day five in relation to sta dard tissue culture 
petri dish (TCPD) substrates (Figure 1). S bsequent removal of EtOH by evacuation was crucial to 
achieve the cytocompatibility. 
 
Figure 1. Viability of human fibroblasts cultured with material extracts for 24 h. 
Cured polyacrylate  (PA) was rinsed  in EtOH  (70%)  for one  to  five days. Extracts  from every 
material sample were tested according to DIN ISO 10993‐5. The cell viability of PA was comparable 
to those cultured on tissue culture petri dishes (TCPD) after washing for four and five days. 
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Cured polyacrylate (PA) was rinsed in EtOH (70%) for one to five days. Extracts from every
material sample were tested according to DIN ISO 10993-5. The cell viability of PA was comparable to
those cultured on tissue culture petri dishes (TCPD) after washing for four and five days.
A slight mass loss of 0.48% ˘ 0.22% was measured after the washing procedure of the PA material
indicated the removal of soluble compounds. The immersion of UV-cured PA in EtOH (70%) hardly
changed the Young’s modulus of the dried material (~18 MPa), while tensile strength dropped from
2.9˘ 0.4 MPa to 1.7˘ 0.1 MPa (Table 1). Immersion of UV-cured PA in PBS resulted in an increase of the
Young’s modulus and tensile strength from 18.8 ˘ 1.7 MPa to 24.6 ˘ 2.3 MPa and from 2.9 ˘ 0.4 MPa
to 3.5 ˘ 0.1 MPa, respectively. After γ-sterilization, the modulus and tensile strength rose from
18.8 ˘ 1.7 MPa to 21.3 ˘ 2.1 MPa and from 2.9 ˘ 0.4 MPa to 3.2 ˘ 0.5 MPa, respectively.
Table 1. Young’s modulus and tensile strength of PA after four min of UV-curing, before and after
additional rinsing for five days in EtOH (70%), and after additional 24 h immersion in physiological
buffer or after additional gamma sterilization.
PA Material Young’s Modulus (MPa) Tensile Strength (MPa)
UV (4 min) 18.8 ˘ 1.7 2.9 ˘ 0.4
UV (4min) + EtOH (70%) treatment and dried in vacuum 18.3 ˘ 0.4 1.7 ˘ 0.1
UV (4 min) + γ-sterilization 21.3 ˘ 2.1 3.2 ˘ 0.5
UV (4 min) + PBS buffer 24.6 ˘ 2.3 3.5 ˘ 0.1
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2.2. Production of Tubular Structures by Stereolithography
For the fabrication of branched and porous tubular structures a protocol for stereolithographic
(SLA) curing of the resin was developed and the curing depth for the SLA process using the new
PA resin was minimized. The curing depth CD was determined at a fixed mean laser power of
25.4 mW. Variation of scan velocities between 50 mm s´1 to 410 mm s´1 resulted in exposure between
160 mJ cm´2 and 1307 mJ cm´2. When plotted in semi-logarithmic scale, the working curve followed
the expected linear relationship (Figure 2). The minimum curing depth was approximately 10 µm
and increased up to 30 µm for higher exposures. For small exposures, i.e., high scanning speeds,
the experimental data slightly deviated from the linear correlation. Based on these results, the layer
separation distance was set to 20 µm to 30 µm for the generation of 3D tubular structures. The SLA
process was then used to assemble linear tubular structures, branched tubular structures, and tubular
structures with defined pores (Figure 3). The total length of the linear tubes was 30 mm, the inner
diameter was 2 mm and the wall thickness was 200 µm. The pore diameter was 100 µm over the full
wall thickness. The length of the branched tubular structures from inlet to outlet was 17 mm, the inner
diameter was 1 mm and the wall thickness was 300 µm.
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according to the design shown in (A). The inner diameter of the smallest branches is 1 mm the wall 
thickness  is 300 μm. The complete construct  is 12 mm wide and 17 mm high. (C) SEM  image of a 
linear porous tube (scale bar: 400 μm). The inner diameter of the tube is 2 mm, the wall thickness is 
200 μm and  the  total  length  is 30 mm.  (D) Magnification of a  single pore  (scale bar: 40 μm). The 
diameter is approximately 100 μm spanning the entire wall crossection of 200 μm. 
Figure 2. Curing depth plotted as a function of exposure. The smallest achievable curing depth for the
PA resin with the used setup was approximately 10 µm.
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structure, kindly provided by the University of Loughborough. (B) SL fabricated tubular structure
according to the design shown in (A). The inner dia eter of the s allest branches is 1 the all
thickness is 300 µm. The complete construct is 12 mm wide and 17 mm high. (C) SEM image of a linear
porous tube (scale bar: 400 µm). The inner diameter of the tube is 2 mm, the wall thickness is 200 µm
and the total length is 30 mm. (D) Magnification of a single pore (scale bar: 40 µm). The dia eter is
approximately 100 µ spanning the entire wall crossection of 200 µm.
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2.3. PA Surface Functionalization with Thio-Modified Heparin and RGDC-Peptides
With regard to providing model systems for small blood vessels we considered the integration of
an endothelial monolayer. Thio-modified heparin and cysteine-coupled RGD were applied in order to
equip the PA surfaces with cell recognition sites to enable the adhesion endothelial cells. Thio-modified
heparin was synthesized by EDC mediated reaction of heparin with the dihydrazide linker DTPH
and subsequent DTT mediated dissociation of the S-S bond. The successful derivatization of heparin
was verified by 1H-NMR (D2O and 500 MHz). Figure 4 shows spectra of unmodified heparin and
a thio-modified derivative. The resonances detected for thio-modified heparin at δ = 2.65 ppm and
δ = 2.85 ppm were assigned to the insertion of two methylene groups by DTPH conjugation.
J. Funct. Biomater. 2016, 7, 11 
5 
2.3. PA Surface Functionalization with Thio‐Modified Heparin and RGDC‐Peptides 
With regard to providing model systems for small blood vessels we considered the integration 
of  an  endothelial monolayer. Thio‐modified heparin  and  cysteine‐coupled RGD were  appl ed  in 
order to equip the PA surfaces with cell recognition sites to enab  the adhesion endothelial cells. 
Thio‐modified heparin was synthesized by EDC media ed reaction of heparin with the dihydrazide 
linker  DTPH  and  subsequent  DTT  mediated  dissociation  of  the  S‐S  bond.  The  successful 
derivatization of heparin was verified by 1H‐NMR (D2O and 500 MHz). Figure 4 shows spectra of 
unmod fi   heparin  and  a  thio‐modified  derivativ .  The  re onances  detected  for  t io‐modified 
heparin at  = 2.65 ppm and  = 2.85 ppm wer  assigned  o the insertion of two methylene groups by 
DTPH conjugation. 
 
Figure  4.  1H‐NMR  spectra  of  heparin  (bottom)  and  thio‐modified  heparin  (top).  Signals  at  the 
chemical shift of  = 2.65 ppm and the chemical shift of  = 2.85 ppm correspond to methylen protons 
of the thio‐functional linker. 
X‐ray  photon  spectroscopy  (XPS) was  applied  in  order  to  investigate  the  chemical  surface 
composition of pristine PA substrates and of PA substrates after incubation with aqueous solutions 
of the biomolecule derivatives. The results are summarized in Table 2. Sulfur (S) and nitrogen (N) 
signals were  taken  as proof  for  the presence  of  thio‐modified  heparin  or RGDC peptides  at  the 
polymer  surface  because  such  elements were  not  present  at  pristine  PA  surfaces. Additionally, 
decreases of  the  atomic percentage of  aliphatic  carbon  (Cali)  indicated  the  formation of  a  surface 
coating, because aliphatic carbon was present mainly in the bulk polymer but only at low ratios in 
heparin and RGDC. The unchanged percentage of Cali in untreated PA and PA treated with RGDC 
together with the absence of S or N indicated that the amount of peptides present at the surface was 
below the detection limit of XPS or that direct coupling of RGDC to the PA surface was not successful 
at all. 
In  contrast, at PA  surfaces  treated with  thio‐modified heparin or  thio‐modified heparin and 
RGDC, S and N were clearly detected. The relative amounts of S detected after functionalization with 
thio‐heparin  and  functionalization with  thio‐modified  heparin/RGDC was  0.3  at.%  and  0.4  at.%, 
respectively,  not  indicating  any  significant  changes  of  the  S  content  upon RGDC  coupling.  The 
relative amount of N increased to 0.6 ± 0.1 at.% upon functionalization with thio‐modified heparin 
and to 1.1 ± 0.1 at.% upon RGDC coupling. The approximated C1ali:N:S ratio of double disaccharide 
units  of  heparin  is  in  the  range  of  0:2:(1–6)  depending  on  the  degree  of  sulfation  and  thio‐
modification. For the RGDC peptide the ratio is 2:8:1, thus the prominent increase of the N signal 
compared to the smaller increase of the S signal indicated the coupling of RGDC peptides to the thio‐
heparin coated surfaces. 
Figure 4. 1H-NMR spectra of heparin (bottom) and thio-modified heparin (top). Signals at the chemical
shift of δ = 2.65 ppm and the chemical shift of δ = 2.85 ppm correspond to methylen protons of the
thio-functional linker.
X-ray photon spectroscopy (XPS) was applied in order to investigate the chemical surface
composition of pristine PA substrates and of PA substrates after incubation with aqueous solutions
of the biomolecule derivatives. The results are summarized in Table 2. Sulfur (S) and nitrogen (N)
signals were taken as proof for the presence of thio-modified heparin or RGDC peptides at the polymer
surface because such elements were not present at pristine PA surfaces. Additionally, decreases of
the atomic percentage of aliphatic carbon (Cali) indicated the formation of a surface coating, because
aliphatic carbon was present mainly in the bulk polymer but only at low ratios in heparin and RGDC.
The unchanged percentage of Cali in untreated PA and PA treated with RGDC together with the
absence of S or N indicated that the amount of peptides present at the surface was below the detection
limit of XPS or that direct coupling of RGDC to the PA surface was not successful at all.
In contrast, at PA surfaces treated with thio-modified heparin or thio-modified heparin and
RGDC, S and N were clearly detected. The relative amounts of S detected after functionalization
with thio-heparin and functionalization with thio-modified heparin/RGDC was 0.3 at.% and 0.4 at.%,
respectively, not indicating any significant changes of the S content upon RGDC coupling. The relative
amount of N increased to 0.6 ˘ 0.1 at.% upon functionalization with thio-modified heparin and to
1.1 ˘ 0.1 at.% upon RGDC coupling. The approximated C1ali:N:S ratio of double disaccharide units of
heparin is in the range of 0:2:(1–6) depending on the degree of sulfation and thio-modification. For the
RGDC peptide the ratio is 2:8:1, thus the prominent increase of the N signal compared to the smaller
increase of the S signal indicated the coupling of RGDC peptides to the thio-heparin coated surfaces.
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Table 2. Results of XPS analysis of PA surfaces without treatment, after immersion with RGDC solution,
solution of thio-modified heparin, or both biomolecules in sequence: 168.2 eV to 168.4 eV binding
energy of sulfate-sulfur, 163.4 eV binding energy of sulfur from S–C bonds, 399.7 eV to 401.4 eV
binding energies of nitrogen in amide bonds and amino functions, 284.6 eV binding energy of aliphatic
C-C bonds.
Title Untreated PA RGDC Thio-Modified Heparin Thio-Modified Heparin/RGD
Mean average/at.%
C1 (284, 6 eV) 49.4 50.3 46.6 45.0
S1 (168.2 eV to
168.4 eV) 0.0 0.0 0.2 0.2
S2 (163.4 eV) 0.0 0.0 0.1 0.2
N total 0.0 0.0 0.6 1.1
Standard deviation/at.%
C1 (284, 6 eV) 2.5 0.1 0.1 0.5
S1 (168.2 eV to
168.4 eV) 0.0 0.0 0.0 0.0
S2 (163.4 eV) 0.0 0.0 0.0 0.1
N total 0.0 0.0 0.1 0.1
2.4. Endothelial Cell Culture on Planar and Tubular Substrates
The adhesion and proliferation of human dermal microvascular endothelial cells (HDMEC) on
planar material samples of pristine PA and functionalized PA were investigated after 24 h (Figure 5).
On PA coated with thio-modified heparin and RGDC, a confluent cell monolayer formed comparable
to that on TCPD. On non-functionalized PA and on surfaces that had been treated with the RGDC
peptides or the thio-modified heparin separately, non-confluent cell colonies were found.
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seeded  on  various  surfaces  for  24  h:  (A)  Tissue  culture  petri  dish  TCPD  as  control  surface;  (B) 
Untreated PA; (C) Polyacrylate (PA) functionalized with thio‐modified heparin; (D) PA treated with 
cysteine‐coupled  arginine‐glycine‐aspartic  acid  (RGDC);  and  (E)  PA  functionalized  with  thio‐
modified heparin/RGDC (scale bar: 200 μm). Only few cells attached to the non‐functionalized PA as 
well as on  the PA  treated with  thio‐modified heparin or RGDC. The  functionalization with  thio‐
modified heparin/RGDC resulted in a confluent cell monolayer comparable to the TCPD. 
For  seeding  HDMECs  to  the  luminal  walls  of  PA  tubes,  static  and  rotating  setups  were 
compared. Static  incubation of  cell  suspension within  the  tube  lumen  resulted  in  cell attachment 
exclusively at the tubes´ bottom and thus in inhomogeneous cell layers. When the non‐porous tube 
was rotated for 4 h during cell attachment homogenous endothelial cell adhesion to the complete 
inner tube wall was achieved. Cell attachment was generally lower on non‐functionalized tubes than 
on biofunctionalized PA  tubes  (Figure 6). For porous  tubes,  the seeding procedure was modified. 
Figure 5. Light microscopic images of Human dermal microvascular endothelial cells (HDMECs)
seeded on various surfaces for 24 h: (A) Tissue culture petri dish TCPD as control surface;
(B) Untreated PA; (C) Polyacrylate (PA) functionalized with thio-modified heparin; (D) PA treated with
cysteine-coupled arginine-glycine-aspartic acid (RGDC); and (E) PA functionalized with thio-modified
heparin/RGDC (scale bar: 200 µm). Only few cells attached to the non-functionalized PA as well
as on the PA treated with thio-modified heparin or RGDC. The functionalization with thio-modified
heparin/RGDC resulted in a confluent cell monolayer comparable to the TCPD.
For seeding HDMECs to the luminal walls of PA tubes, static and rotating setups were compared.
Static incubation of cell suspension within the tube lumen resulted in cell attachment exclusively at
the tubes’ bottom and thus in inhomogeneous cell layers. When the non-porous tube was rotated for
4 h during cell attachment homogenous endothelial cell adhesion to the complete inner tube wall was
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achieved. Cell attachment was generally lower on non-functionalized tubes than on biofunctionalized
PA tubes (Figure 6). For porous tubes, the seeding procedure was modified. After 1 h rotation, cells
were further allowed to proliferate for four days while cultured statically to compose a confluent
monolayer in porous tubes. Assumingly, this was necessary because part of the cells were lost due to
transiting the porous tube walls.
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HDMECs expressed CD31 and vWF when cultured under static and dynamic conditions: (A–C)
CD31; (D–F) vWF; (A,D) static culture of HDMECs on TCPD (control); (B,E) static culture of HDMECs
on PA functionalized with thio-modified heparin/RGDC; and (C,F) dynamic culture of HDMECs for
seven days in a tubular PA material functionalized with thio-modified heparin/RGDC. Arrow shows
the direction of flow (scale bar: 50 µm).
2.5. Characterization of Hemolytic Potential and Platelet Adhesion
With regard to future uses of endothelialized surfaces in direct contact with blood, we preliminary
addressed hemocompatibility of PA and coated surfaces in terms of hemolysis and platelet adhesion.
The hemolytic activity of all surfaces tested was below 1% of the positive control and none of the
surfaces provoked any hemolysis significantly different from the negative control (Figure 8).
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positive control. (B) Platelet adhesion to the various surfaces. The results are shown as percentage of 
LDH activity detected after  lysis of adhered platelets, the positive control was the LDH activity of 
platelets  adhered  to  collagen  type  I  surfaces  and was  set  to  100%.  BSA‐coated  TCPD  served  as 
negative control. (C) Platelets adhered to collagen type I; (D) BSA‐coated TCPD; (E) unmodified PA; 
(F) PA  functionalized with  thio‐modified heparin;  and  (G) PA  functionalized with  thio‐modified 
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Light microscopic surface analysis revealed  that  the positive control surface  (collagen  type  I) 
was densely covered with platelets, while considerably fewer platelets were found on the negative 
control (BSA‐coated TCPD) and unmodified PA (Figure 8). On the surfaces functionalized with thio‐
modified heparin and thio‐modified heparin/RGDC, more platelets adhered than to the unmodified 
PA. Very few activated platelets were observed. The relative quantification of adhered platelets was 
achieved by quantification of the amount of released LDH after platelet lysis (Figure 8). The results 
confirmed that platelet adhesion to unmodified PA (10.9% ± 9.8%) was similar to the negative control 
Figure 8. Hemolysis and platelet adhesion: (A) Hemolysis of erythrocytes on pristine and
functionalized PA. Blood of three donors was tested on the materials in triplicates, and the results are
shown as percentage of a positive control (erythrocytes lysed in water). For all tested materials the
observed hemolytic activities were in the range of the negative control and < 1% in relation to the
positive control. (B) Platelet adhesion to the various surfaces. The results are shown as percentage
of LDH activity detected after lysis of adhered platelets, the positive control was the LDH activity
of platelets adhered to collagen type I surfaces and was set to 100%. BSA-coated TCPD served as
negative control. (C) Platelets adhered to collagen type I; (D) BSA-coated TCPD; (E) unmodified
PA; (F) PA functionalized with thio-modified heparin; and (G) PA functionalized with thio-modified
heparin/RGDC. Activated platelets are marked with an arrow. Scale bar: 20 µm.
Light microscopic surface analysis revealed that the positive control surface (collagen type I) was
densely covered with platelets, while considerably fewer platelets were found on the negative control
(BSA-coated TCPD) and unmodified PA (Figure 8). On the surfaces functionalized with thio-modified
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heparin and thio-modified heparin/RGDC, more platelets adhered than to the unmodified PA.
Very few activated platelets were observed. The relative quantification of adhered platelets was
achieved by quantification of the amount of released LDH after platelet lysis (Figure 8). The results
confirmed that platelet adhesion to unmodified PA (10.9% ˘ 9.8%) was similar to the negative control
(16.9% ˘ 19.1%). Significantly higher numbers of platelets adhered to the coatings of thio-modified
heparin (40.2% ˘ 23.6%). The adhesion to surfaces coated with thio-modified heparin/RGDC seemed
to be at an elevated level (29.4% ˘ 26.0%) though not significant.
3. Discussion
Additive manufacturing methods are gaining importance in the fabrication of small-caliber
artificial vascular grafts. Currenlty, no appropriate material is available that can be used in biological
applications and in medical engineering in medicine. In this study, we investigated means to achieve
cytocompatibility and biofunctionality of a new material formulation which was used to construct
porous tubular structures with photo-curing based additive assembly by stereolithography.
3.1. Post-Curing Treatments of UV-Cured PA
We observed decreasing cytotoxicity upon extensive immersion EtOH (70%) suggesting that
soluble substances with elevated toxicity, e.g., the photoinitiator Irgacure 184 which has been shown to
be cytocompatible at low concentration (< 0.02% [29,30]) or unreacted monomers remained within
the polymer network after UV crosslinking and were then removed during rinsing. This observation
was accompanied by a mass loss of 0.5% of the dried polymers before and after rinsing with EtOH.
A moderate decrease of the Young’s modulus and a strong dropping in tensile strength was also
observed after the washing procedure with EtOH (70%) while a rise in the Young’s modulus was
observed upon exposure to PBS. We assume that microscopic destruction of the polymeric network
occurred due to an elevated degree of swelling in EtOH. In spite of the hydrophobic properties of
PA we detected a small uptake of 1% to 2% (w/w) water into the polymer bulk material. Therefore,
we propose that in the case of PBS the swelling effects resulted in an expanded (but not destructed)
network with higher mechanical values.
The increase in modulus and tensile strength after γ-irradiation is assumed to be the result of
increased degree of crosslinking of the polymer precursor molecules. The γ-radiation consists of higher
energy and ingresses deeper into the material than UV radiation. Therefore, additional crosslinking of
remaining monomers and elevated strength of the material has to be taken into account for γ-irradiated
material in comparison to non-treated PA.
The elastic properties of native arteries are highly complex (anisotropy, viscoelasticity,
and non-linear stress-strain relationship) and currently unmet by the use of synthetic materials.
The material presented here was rather intended to provide adequate handling features required for
mounting the perfusion systems into the bioreactor, than as proper mechanical model for blood vessels.
The mechanical testing results showed that the solid cured-PA was sufficiently elastic and durable
but surmounted the elasticity of natural blood vessels of around 2 MPa only to some extent [31].
The properties of porous PA tubes will be characterized and adjusted in additional studies in terms of
their mechanical answer to pulsed blood pressure and physical stretching.
3.2. Production of Tubular Structures by Stereolithography
The vertical resolution is a critical value for the generation of tubular structures by SLA. It is
determined by the curing depth, which depends on the penetration depth of the employed wavelength
within the photosensitive material. Thus, the curing depth can be minimized by increasing the
absorption cross-section of the photosensitive material or by reducing the exposure from the SLA
apparatus by, e.g., increasing the scanning speed. In our study, reduction of exposure and thus
reduction of crosslinking density resulted in insufficient mechanical strength for the generation of 3D
structures. Consequently, 2,2'-dihydroxy-4,4'-dimethoxy-benzophenon was added as an absorber to
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increase the absorption cross section of the photosensitive material. For this resin formulation the
exposure and the curing depth showed the expected linear correlation on a semi-logarithmic scale.
The deviation from the linear correlation for small exposures, i.e., high scanning speeds was most
probably due to the fact that at a pulse repetition rate of 20 kHz the pulse overlap was decreasing for
the upper scan speeds. The lateral distance between two laser pulses at a scan speed of 400 mm s´1
was 20 µm and therefore almost as large as the beam waist, such that the curing depth reached
the minimum.
The freeform capabilities of the SLA process can be used to incorporate additional structural
functionalities into the 3D tubular structure. For the generation of artificial supply systems for
biological tissue models we chose to develop a hydrophobic material composition in order to avoid
extensive swelling and thus geometrical changes of the tubes within aqueous environments. As a
consequence, the vessel walls had to be porous in order to allow the free exchange of water and
nutrients into and from surrounding tissue as well as the passage of cells, e.g., for neoangiogenesis.
We demonstrated that the presented material process combination allowed for fabrication of tubular
structures with well controlled 100 µm pores.
In the future, the pore size must be reduced to 20 µm or smaller to allow endothelial cells to cover
the pores and to achieve a physiological barrier controlled by the endothelial layer [32,33]. Currently,
higher resolutions required reduced laser intensities and thus resulted in decreased mechanical
stabilities. In order to overcome such hurdles, further tuning of material properties and curing
parameters will be addressed in future studies.
3.3. PA Surface Functionalization with Thio-Modified Heparin and RGDC-Peptides
Endothelial cells are known to bind to proteins from the basement membrane (e.g., collagens,
laminin, perlecan, and fibronectin), serum proteins (fibrin and fibrinogen) or the respective
integrin-binding epitopes including RGD, YIGSR, and GFOGER [34–36]. Some studies reported
that coating with heparin improved EC adhesion to surfaces. The interaction of surface bound heparin
with the heparin-binding domain of fibronectin is discussed as one possible mechanism mediating
cell adhesion [37], but the interaction of heparin with endothelial cells is not completely understood
yet [38–40] and most studies heparin-based coatings alone only supported initial cell adhesion but
cell loss and irregular cell shapes were observed after some time [37]. In order to achieve stable
endothelial lining of the tube surfaces we combined heparin with RGD peptide coupling. We used
thio-modified heparin and RGD-cysteine to modify the PA surfaces. PA surfaces eventually contain
unreacted acrylate functions (C=C) after curing [26]. Such remaining double bounds (RDB) can be used
for the conjugation of thio-functional molecules via thiol-Michael reactions. Although the covalent
coupling of thio-functions to acrylate functions at the PA surface could not be deduced from XPS
data directly, the increase in Sulfur (S) content and the change in N:S ratio at the PA surface indicated
heparin immobilization and RGDC coupling, respectively. While in our hands the direct coupling of
the cysteine to the PA surface was not efficient the thio-functionalized heparin polymers obviously
mediated subsequent coupling of RGDC. We concluded that the thiolated polymer chains, once they
bound to acrylic functions at the PA surface, served as multiplicator displaying a high number of
thio-functions for RGDC coupling via disulfide formation.
3.4. Endothelial Cell Culture on Planar and Tubular Substrates
The effective contribution of short recognition sites such as RGD to cell adhesion in protein-rich
environments as in vivo is discussed controversial [41]. However, in vitro RGD is one of the most often
used cell recognition sequences. It was shown in several studies that RGD enhanced endothelial cell
attachment [42–45]. In accordance with our own results other studies that combined heparin-based
coatings with specific cell adhesion sequences such as fibronectin or RGD, the addition of cell adhesion
sites stabilized or improved [37,38,40] the adhesion of endothelial cells.
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In our hands rotating seeding led to a complete homogenous monolayer of endothelial cells
on the heparin-RGD functionalized inner tube wall. We have shown that endothelial cells stayed
attached and aligned along the media flow even after culturing them for 7 days under fluid flow,
thereby applying the physiological wall shear stress of 1 N m´2 for 2 days. Previous studies had also
shown that endothelial cells, e.g., adhered on RGD-functionalized expanded polytetrafluoroethylene
grafts (ePTFE) and oriented in the direction of shear stress and formed a cell layer more resistant to
shear stress compared to a fibronectin coating under a shear rate of 0.8 N m´2 for 24 h [46]. Other
authors showed that cells adherent to a RGD-coated polyethylene terephthalate (PET) surface endured
exposure to 12 dyn cm´2 (1.2 N m´2) shear stress, mimicking arterial conditions, for two hours [47].
A higher seeding efficiency was additionally observed when using endothelial progenitor cells on
RGD-coated surfaces compared to human umbilical vein endothelial cells (HUVECs) [48].
3.5. Characterization of Hemolytic Potential and Platelet Adhesion
Although intended for in vitro use in its current state, we also assessed the new PA material and
its coatings in a preliminary study with regard to hemolytic and platelet-adhesive effects. As expected,
none of the surfaces showed hemolytic activities. However, thio-modified heparin as well as
heparin/RGDC coated surfaces seemed to slightly mediate platelet adhesion in contrast to unmodified
PA. It is known that contact activation of platelet integrins, e.g., by the RGD sequence generally leads
to platelet adhesion, spreading and thrombus formation at surfaces [49–52]. Interestingly, some in vivo
experiments also proofed reduction of platelet adhesion on RGD functionalized surfaces compared to
unmodified polymers such as PCL [53].
Profound platelet adhesion to thiol-groups was also reported for thiolated surfaces that carried
low surface charge densities [54]. It is discussed to be mediated by the existence of free thiol-groups on
the surface of platelets [55,56]. The surfaces described here also allow for the assumption that masking
of free thio-groups of thio-modified heparin has occurred by RGDC peptide coupling via disulfide
formation and may have thereby reduced platelet adhesion. Still, the thrombogenic potential of the
surface stayed on an elevated level consistent with the observation of other authors, who reported
αIIbβ3 integrin mediated adhesion of platelets to the RGD sequence [52]. In contrast to the results of
Corum et al. hydrophobicity of the untreated PA alone did not result in elevated platelet adhesion [54].
4. Experimental Section
4.1. Preparation of (co-BPA-co-IBA-co-IL)-Polyacrylate in Planar and Tubular Geometry
Bisphenol A ethoxylate diacrylate (M = 688 g mol´1) (BPA), lauryl acrylate (LA), and isobornyl
acrylate (IBA) were purchased from Sigma Aldrich®; Irgacure® 184 was used as photoinitiator (kindly
provided by Ciba AG, Basel, Switzerland). First, 49.75% BPA, 37.31% IBA, 12.44% IL and 0.5% Irgacure®
184 were blended (PA-resin) and used for sample preparation by curing with UV light under an argon
atmosphere. The cured polyacrylate, a statistical (co-BPA-co-IBA-co-IL)-polyacrylate (PA), has been
described recently [57].
4.1.1. Planar Sample Preparation
The volume of 0.3 mL PA-resin was loaded into a polystyrene petri dish (diameter 35 mm),
flushed with argon, and irradiated 4 min with full UV spectra (Bluepoint 4 ecocure, Hoenle, Germany:
40 mW cm´2 at 365 nm).
4.1.2. Tubular Sample Preparation by Dip Coating
Small glass rods (d = 2 mm, L = 75 mm; Marienfeld, Lauda-Königshofen, Germany) were dip
coated manually into PA-resin, led drop off surplus material while smoothly turning the tubes between
two fingers, placed in a glass beaker and UV cured for approximately 1 min while permanently flushed
with argon. The procedure was repeated six times. Subsequently, these multilayers were flushed with
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argon and irradiated for 4 min. The PA coated glass rod was left in water overnight to separate the
coating easily from the glass rod remaining PA tubes with 2 mm inner diameter.
4.1.3. Tubular Sample Preparation by SLA
For the preparation of AM generated tubular samples an SLA setup was used. An UV laser
source (FTSS 355-Q2, CryLaS GmbH, Berlin, Germany) emitting laser pulses with a pulse duration
of approximately 1 ns at a wavelength of 355 nm was focused by a f-Theta lens with a focal length
of 100 mm (JENar® 03-70FT-100-355, JENOPTIK Optical Systems Inc., Jena, Germany). The laser
focus can be translated using a scanner system (PS2-10, Cambridge Technology, Planegg, Germany)
and yields a maximum working field of 52 mm ˆ 52 mm. The resulting beam waist was measured
by a beam analyzing camera (SP620U, Ophir Optronics Solutions Ltd., Darmstadt, Germany) to
approximately 30 µm. For sample preparation, the laser source was set to a repetition rate of
20 kHz and the photosensitive resin was placed in a small volume vat. For SLA, 0.1% (w/w) of
2,2'-dihydroxy-4,4'-dimethoxy-benzophenon was added to the resin as an absorber to reduce the
curing depth. The tubular structures were built in a layer-by-layer approach, with a layer separation
distance of 20 µm. The curing depth CD was determined for different exposures E applying the
following equation [58]:
CD “ DP ˆ ln
ˆ
E
Ecrit
˙
(1)
where DP denotes the penetration depth at which the initial intensity is reduced to 1/e (~37%) and
Ecrit is the critical exposure necessary to initiate polymerization.
4.2. Sterilization
Gamma (γ)-sterilization for the mechanical tests was performed by a certified commercial service
provider (BBF Sterilisationsservice GmbH, Kernen-Rommelshausen, Germany) at approximately
30 kGy.
4.3. Characterization of Young’s Modulus and Tensile Strength of PA
Samples were cured using full spectra UV in a silicon bone template for 4 min under argon
atmosphere and measured with Zwick/Roell 1445 (Zwick, Ulm, Germany). Samples were prepared
with: (a) no further treatment; (b) after γ-sterilization; (c) washed for five days in 70% EtOH then dried
in vacuum overnight at 40 ˝C; and (d) like (c), followed by exposing to PBS buffer for 24 h.
4.4. Evaluation of the Cytocompatibility
The cytocompatibility of post-cured PA was characterized according to DIN ISO 10993-5 [27].
For extract preparation planar PA samples were covered with 3 mL DMEM (Biochrom, Berlin,
Germany) for 24 h at 37 ˝C under static conditions. Human dermal fibroblasts were seeded in
96-well tissue culture polystyrene plates (104 cells per well). PA extracts were then pipetted onto the
cell cultures (200 µL per well), 10% FCS per well was added and cells were incubated for 24 h at 37 ˝C.
Cells incubated in DMEM were provided as a negative control. The cell viability was determined
by WST-1 assay (Roche, Mannheim, Germany) according to the manufacturer’s protocol using a
microplate reader (Infinite 200 Pro, Tecan, Crailsheim Germany). Mass loss (%) was calculated from
tubular PA samples (n = 12). The vacuum dried mass was determined before and after extracting tubes
with 70% EtOH for a period of five days:
%mass loss “
˜
m pPA tubeqa f ter
m pPA tubeqbe f ore
¸
ˆ 100 (2)
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4.5. Synthesis of 3,3-Dithiobis(Propanoic Dihydrazide) (DTPH)
The synthesis was performed based on Vercruysse et al. [59]. Five grams of 3,3- dithiodipropionic
acid were diluted in 40 mL absolute methanol with a few drops of oleum. The mixture was refluxed
under argon for 1 h. The reaction mixture was concentrated to 10 mL volume, diluted in ethylacetate
and washed with 1 M NaOH and water. The organic phase was dried in vacuum to yield the ester.
Five grams of the product were dissolved in 40 mL ethanol (EtOH) and added to 15.75 g hydrazine
hydrate. The solution was warmed up, stirred for 4 h, and the product was then precipitated through
cooling to 4 ˝C. The filtered and washed crystals were dried under vacuum. 1H-NMR: (DMSO-d6)
δ 9.07 (s, 2H, NH2–NH–CO–), 4.20 (s, 4H, NH2–NH–), 2.89 (t, 4H, S–CH2–), 2.41(t, 4H, –CH2–CO–).
4.6. Synthesis and Characterization of Thio-Modified Heparin
Heparin sodium salt was chemically modified following Shu et al. [60]. Briefly, 476 mg DTPH
were dissolved in 20 mL double distilled water (ddH2O). Five hundred milligrams heparin (CAS
01.08.9041, Aldrich, Germany) and 192 mg 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimid (EDC,
CAS 25952-53-8, Fluka, Darmstadt, Germany) were added and the reaction mixture was stirred for 4 h
at pH 4.75, then increased to pH 8. Then, 1.54 g dithiothreitol (DTT) were added and stirred overnight.
The solution was dialyzed first in 0.3 M NaCl solution with 0.1% benzyl alcohol at pH 3.5, then in
ddH2O with 0.1% benzyl alcohol at pH 3.5, and then in ddH2O. The purity of the product and the
substitution of thio-groups were verified by 1H-NMR.
4.7. PA Surface Functionalization with Thio-Modified Heparin and RGDC-Peptides
For surface functionalization with thio-modified heparin or RGDC peptides, PA was incubated
overnight with thio-modified heparin (2 mg mL´1) or RGDC (0.2 mg mL´1) in PBS buffer (pH 7.2) at
room temperature (RT) on a shaker. Afterwards, the samples were washed three times with ddH2O.
Sequential functionalization of PA surfaces with thio-modified heparin and RGDC via disulfide
formation was performed according to Kirihara et al. [61]. After immobilization of thio-modified
heparin, the samples were immersed at RT with 0.25 mg mL´1 RGDC, 0.125 nmol mL´1 potassium
iodide (Fluka, Darmstadt, Germany) and 3% hydrogen oxide (14.7 µmol mL´1, Sigma-Aldrich,
Germany) and shaken for 10 h. Subsequently, the samples were rinsed with ddH2O. For disinfection,
all samples were incubated with 70% EtOH for 0.5 h before seeding of cells.
4.8. Endothelial Cell Culture on Planar and Tubular Substrates
4.8.1. Cell Culture on Planar Substrates
Human dermal microvascular endothelial cells (HDMECs) were seeded at a density of 105 cells on
planar PA samples per dish (diameter: 35 mm) in endothelial cell growth medium (ECGMmv) media
(PromoCell, Heidelberg, Germany) to evaluate cell adhesion and proliferation. Cells were incubated at
37 ˝C for 24 h and then analyzed by bright-field microscopy (Nikon, Düsseldorf, Germany).
4.8.2. Cell Culture on Tubular Substrates
HDMECs were seeded to the inner walls of tubular scaffolds at 8 ˆ 106 HDMECs mL´1 using
either a static set up or rotating the tube at 0.5 rpm for 1 h (porous tubes) or 4 h (non-porous tubes) at
37 ˝C. Porous tubes were then statically cultured for four days to allow cell proliferation.
For dynamic culture of HDMECs in tubes, a fluid flow bioreactor (Unitechnologies SA, Gals,
Switzerland) was used. Upon adhesion, HDMECs were cultured experiencing a wall shear stress
of 0.012 N m´2 for 24 h. The shear stress was then increased at a rate of 0.012 N m´2 h´1 up to the
maximum of 1 N m´2, which is comparable to the shear stress experienced by endothelial cells in
native capillaries [28].
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Laminar wall shear rate was calculated as followed:
τwall “ 4ˆ vˆ ηri (3)
where τwall in N m´2 is the wall shear rate, v in m s is the velocity of the fluid, η in Ns m´2 is the
dynamic viscosity of the fluid and ri in m is the inner radius of the tube.
The cells were cultured for 48 h with a wall shear rate of 1 N m´2. During 7 days two media
exchanges were performed.
4.9. Staining of Cells
For the detection of viable cells within the tubes, 3-(4, 5-dimethylthiazolyl-2)-2,5- diphenyl
tetrazolium bromide (1 mg mL´1; MTT; Sigma-Aldrich, Taufkirchen, Germany) in ECGMmv
medium (PromoCell, Germany) was pipetted into the tubes and incubated for 45 min at 37 ˝C.
For immunofluorescence staining of the endothelial cell marker CD31 and von Willebrand Factor
(vWF) cells were fixed using 4% phosphate-buffered formaldehyde (Roth, Karlsruhe, Germany) for
15 min. Prior to blocking with 3% BSA/PBS for 30 min, cells for vWF staining were permeabilized
using a PBS/0, 1% Triton-X-100 (Sigma-Aldrich, Taufkirchen, Germany) solution for 10 min at RT.
Primary antibodies were diluted with antibody diluent (all DAKO, Germany; vWF: 1:600; CD31: 1:800)
and incubated overnight at 4 ˝C. Then, Cy3-labeled secondary antibody (1:1000; Jackson Immuno
Research, Suffolk, UK) was applied for 0.5 h. Nuclei were stained with DAPI (1:1000) for 15 min in the
dark and cells were analyzed in PBS+ with a laser scanning microscope (Zeiss, Jena, Germany).
4.10. Hemolysis and Platelet Adhesion
Hemolysis and platelet adhesion were assessed as described in Motlagh et al. [62]. For hemolysis
testing, heparinized blood from three healthy volunteers was used. All samples were probed with
blood from each donor in triplicates. Briefly, 0.4 mL whole blood was diluted in 20 mL physiologic
salt solution. One milliliter was pipetted onto each sample or into tissue culture petri dishes (TCPD;
negative control) in triplicates. Complete lysis of the erythrocytes was achieved by addition of 10 mL
sterile ddH2O to 0.2 mL donor blood (positive control on TCPD). All samples were incubated under
gentle agitation for 2 h at 37 ˝C. Afterwards, the blood dilutions were centrifuged at 13,250 g for 10 min.
Absorbance of released hemoglobin was measured at 541 nm in 96-well plates using a microplate
reader (Infinite 200 Pro, TECAN, Crailsheim, Germany). The percentage of hemolysis was calculated
as follows:
%Hemolysis “ absorbance o f test polymer
absorbance o f positive control
ˆ 100 (4)
For platelet adhesion testing, human platelet concentrates (HPC; leukocyte-depleted, each
pooled from four donors) were purchased from the Institute for Transfusion Medicine of the
Katharinenhospital (Klinikum Stuttgart, Stuttgart, Germany). Six independent experiments were
conducted, each including all material samples in triplicates. Collagen gels (6 mg mL´1; Fraunhofer
IGB, Stuttgart, Germany) on TCPD served as positive control, TCPD surfaces modified with BSA (40%)
were used as negative control [63]. Cell counting of the HPCs resulted in counts between 7.97ˆ 106 cells
mL´1 and 8.79 ˆ 106 cells mL´1. In total, 250 µL cm´2 HPC were incubated on every sample at 37 ˝C
for 1 h. The surfaces were carefully washed three times with PBS to remove non-adhered platelets.
Light-microscopic pictures were taken (Nikon, Germany). Subsequently, the adhered cells were lysed
with PBS/2% Triton-X-100 at 37 ˝C for 30 min. Lactate dehydrogenase (LDH) activity (in Unit L´1)
was assessed from supernatants with the RX Daytona analyzer (Randox, Crumlin, United Kingdom).
Platelet adhesion was calculated in correlation to the platelets that adhered to the positive control
as follows:
%Platelet adhesion “ LDH activity on tested sample
LDH activity on collagen
ˆ 100 (5)
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5. Conclusions
The presented material system consisting of a photo-crosslinkable polymer resin, which forms
a cytocompatible elastic polymer upon UV curing, and a biofunctional coating contributes to the
development of a new class of materials that fulfill a range of current demands associated with
biomaterials. In particular, fabrication of complex structures comes more and more into focus,
in addition to non-toxicity, sterilizability and the potential to achieve genuine biological surfaces,
i.e., endothelialization. In this study, we present a polyacrylate resin that can be photo-cured to
generate scaffolds in various geometries using a photoinitiator and UV irradiation. We fabricated
complex tubular structures with multiple branches and defined pores by stereolithography and
achieved biofunctionalization and confluent endothelial lining of the inner tube walls within a flow
bioreactor. In conclusion, we provide a technology platform that enables additive freeform fabrication
of complex cytocompatible objects covering structure sizes from the µm range to cm range with
biofunctional surfaces, and thus being promising for sophisticated scaffolding for in vitro tissue models
and for individualized medical engineering.
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